
21 08 US PRE OPEN
The S&P 500 futures consolidate ahead of economic data
Share this:
Later today, are due Markit U.S. Manufacturing Purchasing Mangers' Index (August preliminary reading at 52.0 expected), and Services PMI (51.0 expected), and Existing Home Sales (a rise in annualized rate to 5.40 million units in July expected).
European indices are slightly bullish. U.K Office for National Statistics has reported July retail sales at +3.6% (vs +2.0% on month expected). Research firm Markit has published preliminary readings of August Manufacturing PMI for the eurozone at 51.7 (vs 52.9 expected), for Germany at 53.0 (vs 52.5 expected), for France at 49.0 (vs 53.7 expected) and for the U.K. at 55.3 (vs 53.8 expected). Also, preliminary readings of August Services PMI were released for the eurozone at 50.1 (vs 54.5 expected), for Germany at 50.8 (vs 55.1 expected), for France at 51.9 (vs 56.3 expected) and for the U.K. at 60.1 (vs 57.0 expected).
Later today, the European Commission will post August Consumer Confidence Index (-15.0 expected).
Asian indices closed on the upside except the Australian ASX which lost 0.14%. Official data showed that Australia's preliminary retail sales grew 3.3% on month in July (+2.7% in June). Also, Japan's national core CPI was flat on year in July (+0.1% expected).
WTI Crude Oil futures are turning down. U.S. oil export to China may reach 37M barrels in September, surpassing the record level set in May of 35.2M barrels, reported Bloomberg citing the shipping fixtures. Later today, Baker Hughes will report the oil rig counts for the U.S. and Canada; total number of oils rigs operating in the U.S. reported the previous week fell to 172, the lowest since July 2005.
Gold loses ground while the US dollar steadies before the release of important US economic data.
Gold fell 15.68 dollars (-0.81%) to 1931.59 dollars while the dollar index rose 0.34pt to 93.132.
U.S. Equity Snapshot
Pfizer (PFE) and BioNTech, the two pharmaceutical groups which are developing COVID-19 vaccine, said they "are on track to seek regulatory review for BNT162b2 as early as October 2020 and, if regulatory authorization or approval is obtained, currently plan to supply up to 100 million doses worldwide by the end of 2020 and approximately 1.3 billion doses by the end of 2021".
Source: TradingView, GAIN Capital
Deere & Co (DE), a manufacturer of agricultural and construction equipment, is soaring before hours as the raised its full-year net income forecast.
Keysight Technologies (KEYS), a provider of electronic measurement devices and software solutions, released third quarter adjusted EPS of 1.19 dollar, beating estimates, down from 1.25 dollar last year, on adjusted revenue of 1.0 billion dollars, higher than expected, down from 1.1 billion dollars a year earlier.Occidental Petroleum (OXY), an energy exploration and production company, was upgraded to "equal-weight" from "underweight" by Morgan Stanley.
Open an account in minutes
Experience award-winning platforms with fast and secure execution, and enjoy tight spreads from 0.5 pts on FX and 0.3 pts on indices.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

ASX 200 Rebound Stalls Despite Wall Street Surge
The ASX 200 rebound is struggling for traction despite a powerful Wall Street rally, leaving 8800 resistance and downside risks in focus.

Nikkei threatens breakout as tech rebound broadens
Breakouts across the SOX and Nasdaq are being matched by rebounds across Asia, with the Nikkei now threatening to join the move.

Nasdaq 100 Forecast: Confidence Returns as the Index Challenges Record Highs
The trading week is getting underway with renewed bullish momentum across Nasdaq. This is reflected in today's session, where the index has gained more than 2.5%, highlighting a buying bias that has not been observed with this level of strength in several weeks.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.forex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.






